| P50 | author | Shinya Toyokuni | Q42710070 |
| | Shugo Suzuki | Q73302706 |
| | Aya Naiki-Ito | Q80139775 |
| P2093 | author name string | Tetsuro Nagasaka | |
| | Satoru Takahashi | |
| | Yoriko Yamashita | |
| | Shinya Sato | |
| | Masafumi Ito | |
| P2860 | cites work | Napsins: new human aspartic proteinases. Distinction between two closely related genes | Q22008616 |
| | Processing of pulmonary surfactant protein B by napsin and cathepsin H | Q24307595 |
| | Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies | Q24619808 |
| | Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma | Q24650843 |
| | Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas | Q28640483 |
| | Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung. | Q30734938 |
| | Human napsin A: expression, immunochemical detection, and tissue localization | Q33882077 |
| | Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy | Q33947083 |
| | Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis | Q34613189 |
| | Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma | Q35843312 |
| | Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma | Q36216878 |
| | Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms | Q37445203 |
| | Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases | Q37821716 |
| | Clear cell cancer of the ovary | Q38128681 |
| | The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary | Q38389308 |
| | Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary | Q39491379 |
| | HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival | Q39763353 |
| | Annexin IV is differentially expressed in clear cell carcinoma of the ovary | Q39768078 |
| | Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary | Q42849233 |
| | Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma | Q43279006 |
| | The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary | Q43568506 |
| | Cellular distribution of napsin (kidney-derived aspartic protease-like protein, KAP) mRNA in the kidney, lung and lymphatic organs of adult and developing mice | Q43749556 |
| | Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas | Q43778443 |
| | Ovarian clear cell adenocarcinoma | Q44258492 |
| | Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules | Q44261973 |
| | Glypican-3 expression in clear cell adenocarcinoma of the ovary | Q44268931 |
| | Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung. | Q44337507 |
| | Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma | Q44519237 |
| | Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs | Q44778891 |
| | Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus | Q45819596 |
| | Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress | Q46825533 |
| | Napsin A staining in adrenal cortical neoplasms. | Q50871491 |
| | Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. | Q51334457 |
| | Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. | Q51630971 |
| | Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: a case report. | Q53148407 |
| | Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. | Q53963245 |
| | Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A. | Q54945171 |
| | Clear cell carcinoma simulating the "endometrioid-like variant" of yolk sac tumor | Q71761766 |
| | Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential | Q80556490 |
| | Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report | Q80596453 |
| | Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type | Q80713870 |
| | Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary | Q81419871 |
| | Napsin A expression in pulmonary sclerosing haemangioma | Q82458963 |
| | Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung | Q83360044 |
| | Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers | Q83414403 |
| | Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung | Q83780811 |
| | Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma | Q83864135 |
| | Napsin A is differentially expressed in sclerosing hemangiomas of the lung | Q85567576 |
| | Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility | Q86565183 |
| P433 | issue | 1 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 111-117 | |
| P577 | publication date | 2014-04-11 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Napsin A is a specific marker for ovarian clear cell adenocarcinoma | |
| P478 | volume | 28 | |